Comparative Genomics and Characterization of SARS-CoV-2 P.1 (Gamma) Variant of Concern From Amazonas, Brazil
An Expression of Concern on
Comparative genomics and characterization of SARS-CoV-2 P.1 (Gamma) variant of concern from Amazonas, Brazil
by Zimerman, R. A., Ferrareze, P. A. G., Cadegiani, F. A., Wambier, C. G., Fonseca, D. d. N., de Souza, A. R., Goren, A., Rotta, L. N., Ren, Z., and Thompson, C. E. (2022). Front. Med. 9:806611. doi: 10.3389/fmed.2022.806611
With this notice, Frontiers states its awareness of ethics concerns surrounding the article “Comparative Genomics and Characterization of SARS-CoV-2 P.1 (Gamma) Variant of Concern From Amazonas, Brazil” published on 15 February 2022. An investigation is currently being conducted by The Federal University of Health Sciences of Porto Alegre, in accordance with applicable institutional policies and procedures. This expression of concern has been posted while Frontiers awaits the outcome of that investigation. It will be updated accordingly after that time.
Citation: Frontiers Editorial Office (2024) Expression of concern on: Comparative genomics and characterization of SARS-CoV-2 P.1 (Gamma) variant of concern from Amazonas, Brazil. Front. Med. 11:1393692. doi: 10.3389/fmed.2024.1393692
Received: 29 February 2024; Accepted: 11 March 2024;
Published: 26 March 2024.
Approved by:
Frontiers in Medicine Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org